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SUMMARY 
A sensitive method has been utilized for the determination and demonstration 
of activity of deoxycytidylate deaminase in human sera. Variations in different 
diseases were also observed. Elevated values were found in all cases of acute liver 
diseases and acute infections. Serial studies indicated that the enzyme levels were 
correlated with the stages of the diseases. Elevations were also consistently observed 
in lupus erythematosus, and to a lesser extent, in rheumatoid arthritis and other 
collagen diseases. In malignant conditions, about half of the values were elevated. 
Normal results were obtained in most of the other diseases studied. The enzyme levels 
were also measured in some human tissues. The possible significance of the results 
has been discussed in terms of the role that deoxycytidylate deaminase may play in 
DNA synthesis. 
Deoxycytidylate (dCMP) deaminase, which catalyzes the conversion of deoxy- 
cytidylate to deoxyuridylate, is believed to play an important role in the de-novo 
synthesis of DNA. After unilateral nephrectomy of the rat, for example, dCMP de- 
aminase activity is markedly enhanced just prior to an increase in DNA synthesis 
and mitotic activity in the surviving kidney%. Similar increases in dCMP deaminase 
activity have been observed when DNA synthesis and mitosis in liver were stimulated 
by partial hepatectomy2-4. Evidence has also been obtained that the activity of 
dCMP deaminase is regulated by allosteric control through an interplay of end 
products of pyrimidine metabolisms*a. 
The assay of dCMP deaminase in normal adult tissues has been difficult, due 
to the low enzyme activity. A sensitive method has been developed recently in our 
laboratory, which permits the determination of dCMP deaminase activity of human 
tissues and serum’. Since the variations of dCMP deaminase activity in different 
pathological conditions could be of interest in regard to the function of this enzyme 
and to a more complete understanding of abnormal processes, a number of sera and 
tissues have been assayed. The results are described below. 
* This work was supported by U.S. Public Health Service Grant HE-io361-03. 
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MATERIALS AND METHODS 
The major requirement for patient selection was that the patient’s diagnosis 
be well established. Patients with two or more diagnoses which might affect enzyme 
activity were excluded. 
Twelve ml of venous blood were obtained by aseptic technique. The blood was 
allowed to clot at room temperature. The specimen was centrifuged at 3” for 15-20 
min and the serum removed. 1.5 pmoles of M&l, per I ml of serum was added, and 
the specimen stored at -20’ within 2 h after drawing the blood, in order to prevent 
significant loss of enzyme activity. Specimens were assayed in duplicate according 
to the method described by Ressler’. 
The method is based upon the measurement of ammonia formation by means 
of the Berthelot reaction. Saturating concentrations of substrate are used, resulting 
in linearity between enzyme activity and time for several hours permitting use of an 
extended incubated period. The higher substrate concentration, compared to concen- 
trations commonly used, also results in a four to five fold increase in enzyme activity. 
These factors and the high sensitivity of the Berthelot reaction combine to make the 
assay of deoxycytidylate deaminase activity in serum feasible. 
The coefficient of variation of the analysis of serum by this methods is 67/o’. 
All tests in this study were performed in duplicate and when any of the duplicates 
were different by more than 6%, the test was repeated. Most of the results in this 
study are related to the normal range, approximately 0.8-2.6 x IO-~ pmoles of ammo- 
nia produced per minute per ml, at 23’. The correlation between a given disease and 
the test value can, perhaps, best be evaluated by a comparison of the frequency 
distribution of values of patients with a given disease to the distribution of values of 
other individuals (normals and other patients with different diseases). 
A limited number of necropsy specimens were obtained and activity of the 
enzyme was determined in various tissues. 
RESULTS 
Figs. I A and B present the results of serum levels of dCMP deaminase in various 
conditions. The “normal” values, from individuals who were apparently in good 
health, were within a relatively narrow range. Five determinations of serum activity 
in one normal individual done on 3 different days did not indicate a large daily 
variation (Fig. I A). 
Collagen diseases 
Twelve patients with classical rheumatoid arthritis were studied. Most of these 
patients demonstrated higher activity of serum deoxycytidylate deaminase than 
control patients (see Fig. IA). No correlation could be established between the level 
of enzyme activity, the extent of the rheumatic process, the degree of alteration of 
serum proteins, or the chronicity of the disease. 
All four patients with systemic lupus erythematosus studied demonstrated 
definitely increased activity of the enzyme. One patient with scleroderma, and one 
patient with polyarteritis were studied. Each of these 2 patients had increased serum 
activity of deoxycytidylate deaminase. 
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Fig. I. Serum deoxycytidylate deaminase activity in various clinical conditions. The ordinate 
represents serum activity in pmoles x IO-~ of ammonia produced per min per ml at 23’. The nor- 
mal mean and f I standard deviation of the normal values are projected across the graph for 
purposes of comparison. 
Leukemia, lymphomas and carcinonsas 
Sera, of 7 leukemic patients tested, tended to have less enzyme activity than 
any other group. All of these patients, however, were receiving treatment with at least 
one cytotoxic agent at the time the ~eox~~yti~y~ate deaminase activity was measured 
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except one. This latter patient had a value within normal limits and it did not 
change appreciably after cytotoxic agents were administered. Included in this group 
were patients with diagnoses of acute myelomonocytic, acute stem cell, acute and 
chronic granulocytic and chronic lymphocytic leukemia; there was no apparent corre- 
lation between the serum enzyme activity and the types of leukemia studied. 
Twelve patients with malignant neoplasms demonstrated variable serum en- 
zyme activity. About half the values were above the normal range. The enzyme 
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activities in the sera of patients with lymphomas were also variable; 7 of 17 patients 
had increased enzyme activity (see Fig. I A). There was no correlation in these patients 
between enzyme activity and serum uric acid, or the presence of metastatic lesions, 
or liver involvement, with or without jaundice. 
Liver disease 
Sixteen patients with liver disease were studied. Six of the patients had either 
chronic or subacute liver disease. All of the latter six had normal serum activity of 
deoxycytidylate deaminase and activity remained normal in the presence of au exac- 
erbation of their disease. These six patients consisted of 3 with nut~tiona~ cirrhosis, z 
with chronic active hepatitis, and one with subacute viral hepatitis. 
All of the IO patients with acute liver disease had marked increases in serum 
activity of the enzyme. Nine of these patients had infectious, or serum hepatitis; one 
patient had drug-induced hepatitis. The most persistent elevation of serum activity 
of deoxycytidylate deaminase was observed in a patient with acute liver disease who 
also developed renal failure. 
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Fig. 2. Serial study of serum deoxycytidylate deaminase activity during the courses of hospitali- 
zation. A: Three patients with acute viral hepatitis. B. Bacteroides septicemia. C. Surgery. 
Unfortunately we were able to evaluate only a few of the patients with acute 
liver disease for enzyme activity early in the course of their illness (Fig. 2A). Serum 
enzyme activity in most patients with viral hepatitis approached normal values 
approximately two weeks after hospitalization. 
Infectious disease 
Patients with bacterial infections demonstrated high serum activity of dCMP 
deaminase. Following treatment of the infection, enzyme activity became normal in 
all patients, To some degree the level of activity was related to the extent of the 
infection, e.g., urinary tract infections did not seem to exert as much effect on enzyme 
activity as pneumonia or septicemia even though the segmentation rate and WBC 
were comparably elevated. A patient with bacteroides septicemia was followed with 
serial determinations of serum enzyme activity (Fig. z B). We were able to Study only 
one patient w.i,th a documented viral infection. This patient was diagnosed as having 
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varicella pneumonia, and demonstrated elevated serum enzyme activity throughout 
her hospita~zation. 
Other diseases 
A number of patients with other diseases were studied. In general, the results 
were within the normal range. Surgery, however, appeared to be associated with in- 
creased serum activity of the enzyme. Two patients followed before and after surgery 
included one case of a resection of an abdominal aortic aneurysm, and one case of a 
repair of bilateral inguinal hernias. Maximum serum enzyme activity was present 
within 6 h following the operative procedure, and returned to normal levels within 
4 days (Fig. zC). 
The patients with hyperthyroidism were not receiving any therapy at the time 
of the assay. In the patients with ulcerative colitis and regional enteritis, the diseases 
were acute when the test was done. No abnormalities of liver function were detected 
in the patients with infectious mononucleosis. In the patients with renal disease, 
azotemia was present, and the condition was either chronic, or an acute exacerbation 
of a chronic renal disease. 
A limited number of patients in the pediatric age group were studied. The 
patterns of variations of dCMP deaminase activity were similar to those observed in 
adult patients; but the levels of enzyme activity were higher in most of the respective 
conditions. 
Serial studies 
Serial studies were done on 3 patients with acute liver disease (Fig. 2). The 
enzyme levels decreased as the condition improved. The fust value of curve C in 
Fig. 2 A was obtained early in the course of the disease. Decreasing deoxycytidylate 
deaminase activity generally indicated improvement before other serum enzyme 
activities declined. 
Fig. 2B represents a serial study of a patient with bacteroides septicemia. 
Specific therapy was initiated on the 15th hospital day. Fig. 2C shows the effect of 
surgery (repair of bilateral inguinal hernias), upon serum enzyme activity. The 
activity rapidly declined from the first post-operative value. 
Specimens of various tissues were obtained at post-mortem examinations and 
assayed for dCMP deaminase activity. Enzyme activity decreased slowly over several 
days when the tissues were stored at -20’. The results are presented in Table I. The 
highest values were generally found in liver and spleen. One spleen specimen, which 
had considerably less activity than any of the other spleens was from a patient who 
had aplastic anemia and septicemia. 
DISCUSSION 
The data appear to provide some consistencies between serum levels of dCMP 
deaminase and clinical conditions. The causes of the elevation of serum dCMP de- 
aminase activity were not established in the present study. The possibility that the 
enzyme is liberated into the circulation from damaged tissue is consistent with the 
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TABLE I 
dCMP ACTIVITY OF HUMAN TISSUES 
(pmoles x ro-*/min/g tissue at 37’) 




I Hodgkin’s disease 28 
Stage IV 
2 Cerebral abscess - 
S-year-old child 
3 Aplastic anemia 12 
Septicemia 
4 Metastatic carcinoma 21 
Congestive heart failure 
Pneumonia 
5 Pancreatitis, hypertension 20 
Renal failure 
Pneumonia 
6 Metastatic adeno-carci- 12 
noma (Lung primary) 
7 Relatively normal 13.5 
















Skeletal Pan- Spleen Kidney Thymus Thyr, 
muscle creas 
2.5 - 20 - - - 
- - - - 9.6 - 
1.1 9 3.8 - - I.7 
1.6 I7 - - - - 
4.0 - 21.5 - - 
0.3 3.8 27.1 10.8 - - 
0.6 I.3 8 3.8 - - 
elevated levels observed after surgery, as well as in pyogenic infections, acute liver 
disease, and collagen diseases. This explanation would appear unlikely for all of the 
elevations, however, since patients with chronic or subacute liver disease, who had 
elevated levels of other serum enzymes such as SGOT or SGPT, nevertheless had nor- 
mal dCMP deaminase activity. 
The results are consistent with the possibility that elevated dCMP deaminase 
levels are associated with cellular proliferation and increased DNA synthesis. The 
lack of elevated enzyme activity in chronic or subacute liver disease could be related 
to observations that liver damage occurring gradually over prolonged periods may be 
associated with minimal observable changes in DNA synthesisa. 
Perhaps, the serum elevations are related, more specifically, to activity of the 
reticuloendothelial system. Thus elevations were always observed in cases of acute 
liver disease and acute bacterial infections, when DNA synthesis in such cells may 
be expected to be quite active; in cases of collagen diseases or cancer in which the 
response of the reticuloendothelial system to the clinical condition may be less direct, 
elevations of dCMP deaminase activity were less consistent; relatively low levels of 
dCMP deaminase activity were found in patients on cytotoxic drugs; and activity 
in liver and spleen was generally higher than in other tissues. At the present time 
no single hypothesis for elevations of dCMP deaminase activity in the plasma satis- 
factorily explains all of our findings. 
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